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ABSTRACT
Despite the advanced PCR-based assays available, a fraction of the pediatric respiratory infections remain unexplained
every epidemic season, and there is a perception that novel viruses might be present in these specimens. We
systematically collected samples from a prospective cohort of pediatric patients with respiratory infections, that
returned negative results by validated molecular RT–PCR assays, and studied them with a target-independent, high-
throughput sequencing-based approach. We also included a matched cohort of children with no symptoms of
respiratory infection, as a contrast study population. More than fifty percent of the specimens from the group of
patients with unexplained respiratory infections were resolved. However, the higher rate of detection was not due to
the presence of novel viruses, but to the identification of well-known viral respiratory pathogens. Our results show
that already known viral pathogens are responsible for the majority of cases that remain unexplained after the
epidemic season. High-throughput sequencing approaches that use pathogen-specific probes are easier to
standardize because they ensure reproducible library enrichment and sequencing. In consequence, these techniques
might be desirable from a regulatory standpoint for diagnostic laboratories seeking to benefit from the many
advantages of these sequencing technologies.
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Introduction
The rate of discovery of new microbes and of new
associations of microbes with health and disease has
accelerated significantly in the last decade [1–4].
Many factors are contributing to this phenomenon
including those that favour the true emergence of
new pathogens as well as new technologies and para-
digms that enable their detection and characterization
[5–7]. Popular media have focused attention on biode-
fense and emerging infectious diseases, providing a
foundation for unprecedented support of basic and
translational research in host, vector, and microbe
biology, as well as diagnostics and surveillance. New
molecular technologies based on high-throughput
sequencing (HTS) have facilitated discovery [7–10].
Appreciation that more than 75% of emerging infec-
tious diseases represent zoonoses has also had an
impact [11]. Moreover, the databases needed to
recognize microbial sequences improved dramatically
with the development of more sophisticated algorithms
for searching and identification [12,13]. Thus, the cur-
rent accepted vision is that we are in a position to tackle
effectively the problem of the detection of the
“unknown known” (e.g. the unexpected rare pathogen)
while true reliable agnostic pathogen discovery for
detection of the “unknown unknown” (e.g. a true
novel pathogen) is still an art.
According to the latest Global Health Estimates
from the World Health Organization, respiratory
infections are among the five leading causes of death
worldwide, causing near 3 million deaths in 2016
[14]. Acute respiratory infections (ARIs) account for
1–3% of deaths in children less than 5 years of age in
industrialized countries and 10–25% of deaths in devel-
oping countries [14]. ARIs of viral origin are one of the
main causes of hospitalization among those patients,
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who typically suffer more than one episode during the
season [15]. Despite advances, a significant proportion
of the pediatric ARIs remain without a causative agent
every epidemic season [16]. This fact is not exclusive of
ARIs, more than 60% of the cases of viral encephalitis,
and near 65% of all deaths from gastroenteritis and
from foodborne disease, remain unassigned to a
specific pathogen even after syndromic laboratory test-
ing [17–19]. Although there are multiple reasons that
explain these results that are not related with diagnostic
technology failure (e.g. non-infectious causes,
inadequate, late or “investigational” sampling), the per-
ception that there are pathogens lurking undetected in
those specimens is widespread. Unfortunately, no com-
prehensive risk assessments of the threat have been
performed yet. In this report, we performed a systema-
tic study of respiratory specimens collected from a
carefully characterized and highly representative, pro-
spective cohort of pediatric cases suffering unexplained
ARI, and we compared the rate of detection of patho-
gens by utilizing validated molecular assays, and a
comprehensive sequence-independent, high-through-
put sequencing-based analysis. In order to assess for
the clinical relevance of the viral identifications made
by HTS in the specimens collected from the unex-
plained cases of respiratory infections, a second cohort
of age-matched healthy individuals from the same epi-
demiologic environment was also studied with the
same methodology.
Materials and methods
Patients and respiratory specimens
Between September 2012 and June 2013, 1,454 children
<14 years of age with a respiratory tract disease were
admitted to the Severo Ochoa Hospital (Madrid,
Spain), and evaluated by an attending physician. Clini-
cal data recorded included age, gender, gestational age
(when less than 37 weeks), clinical diagnosis, need and
length for oxygen therapy, axillary temperature, dur-
ation of fever, total white blood cell count, C-reactive
protein serum levels, presence of infiltrate/atelectasis
in chest X-rays, administration of antibiotic therapy,
hospital stay, and inclusion in pediatric intensive care
unit. Upper respiratory tract infection (URTI) was
diagnosed when rhinorrhea and/or cough were found
with or without fever in the absence of wheezing, dys-
pnea, crackling rales, or bronchodilator use. Asthma
was diagnosed on the basis of the National Asthma
Education and Prevention Program guidelines
[NAEPP, 2002 retrieved from https://www.nhlbi.nih.
gov/files/docs/guidelines/asthmafullrpt_archive.pdf].
Acute expiratory wheezing was considered to be
bronchiolitis when it occurred for the first time in chil-
dren <2 years. All other episodes of acute expiratory
wheezing were considered wheezing episodes. Cases
were considered Pneumonia when both focal infiltrates
and consolidation in chest X-rays were detected. Cases
of Apparent Life-threatening Event (ALTE) were
defined as an episode that is frightening to the observer
and is characterized by some combination of apnea,
colour change, marked change in muscle tone, choking
or gagging [20]. Fever without source (FWS) was diag-
nosed when otherwise healthy child 3 to 24 months of
age presented with fever of less than 7 days in duration
and in whom alternative infectious etiologies were
ruled out.
Nasopharyngeal aspirates (NPAs) were systemati-
cally taken from these patients and analysed by multi-
plex real-time RT–PCR based on previously published
methods [21–23]. These assays allow for the detection
of the main viral respiratory pathogens including:
Influenza virus A, B and C, Human rhinovirus, Enter-
ovirus, Human orthopneumovirus (Human respirat-
ory syncytial virus), Human bocavirus, Human
metapneumovirus, Adenovirus, Human rubulavirus
1–4 (Human parainfluenza virus) and Human coro-
navirus (229E, OC46, HKU1, and NL63). Fifty-
seven of these NPAs (age range <1 month to 14
years old; 45.6% female and 54.4% male) gave nega-
tive results in all the assays and were included in the
present study. The clinical presentation of these
patients (referred in the text as the “Case” group) is
described in Table 1.
A second group of 70 NPAs taken from a prospec-
tive cohort of 21 age-matched healthy donors was
included as a control (referred in the text as the “Con-
trol” group). The individuals included in the control
group were children visiting the hospital for other
causes (e.g. food allergy testing) with no history of res-
piratory infection 10 days before to 10 days after their
visit. These patients came from the same geographic
area as the patients with respiratory tract disease and
the NPAs were collected during the same period of
time covering the epidemic season of virus circulation,
and analysed with the molecular assays as described
above, always resulting negative.
The study was approved by the Medical Ethics
Committee of the Instituto de Salud Carlos III (CEI
PI 15_2012) and informed written consent was
obtained from all participants.
Virus identification by target-agnostic high-
throughput sequencing analysis
All 127 respiratory specimens included in the study
were processed and sequenced individually. From
each NPA, a 200 μl-aliquot was homogenized by pas-
sing the sample through 1 ml sterile syringes with
25G needles (Becton Dickinson, New Jersey, USA)
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Table 1. Clinical presentation of the 57 pediatric patients included in the study.
Sample Gender Age Fever Max. Temp. Fever Length Hypoxia Hypoxia Length Hosp. Length Torax Rx Blood Culture WBC count CRP test Diagnosis Antibiotics ICU
1 F 27 No NA NA No NA 2 Not Performed Not Performed ND ND Bronchiolitis No No
2 M 4,072 No NA NA Yes 3 4 No Alterations ND 12,980 4.0 Asthma No No
3 M 2,717 Yes 39.0 1 Yes 2 3 No Alterations Not Performed ND ND Bronchiolitis No No
4 M 448 Yes 38.4 2 No NA 3 Infiltrates/Atelectasis ND 30,630 24.0 Pneumonia Yes No
5 M 1,375 No NA NA Yes 1 2 Not Performed Not Performed ND ND Asthma No No
6 M 1,257 Yes 38.0 2 Yes 3 4 Infiltrates/Atelectasis Negative 11,390 82.0 Asthma No No
7 F 24 No NA NA No NA 2 Not Performed Not Performed ND ND URTI No No
8 M 26 No NA NA No NA ND Not Performed Not Performed ND ND URTI No No
9 F 151 No NA NA No NA 3 No Alterations Not Performed 6,090 2.0 Bronchiolitis No No
10 M 353 Yes 38.2 2 No NA 3 No Alterations Not Performed ND ND Wheezing Episode No No
11 F 225 Yes 39.0 1 Yes 1 5 No Alterations Not Performed ND ND Bronchiolitis No No
12 F 693 Yes 38.2 3 Yes 3 ND Infiltrates/Atelectasis Negative 5,400 41.0 Asthma No No
13 M 1,275 Yes 38.9 5 Yes 7 8 Infiltrates/Atelectasis ND 13,460 56.0 Asthma No No
14 F 136 Yes 38.9 2 Yes 7 9 No Alterations Not Performed 21,150 ND Bronchiolitis No No
15 M 1,245 No NA NA Yes 2 3 Infiltrates/Atelectasis Not Performed ND ND Wheezing Episode No No
16 F 367 Yes 38.7 2 Yes 1 2 No Alterations Not Performed ND ND Bronchiolitis No Yes
17 F 626 Yes 38.5 1 Yes 8 8 Infiltrates/Atelectasis ND 9,400 5.0 Bronchiolitis No No
18 F 511 Yes 38.5 1 Yes 2 5 Infiltrates/Atelectasis Negative 22,480 25.0 Wheezing Episode Yes Yes
19 F 53 Yes 38.0 1 Yes 6 10 Infiltrates/Atelectasis Negative 14,070 7.0 Bronchiolitis No No
20 F 957 No NA NA Yes 6 7 No Alterations Not Performed ND ND Wheezing Episode No No
21 M 273 Yes 38.5 2 Yes 2 3 Not Performed Not Performed ND ND Bronchiolitis No Yes
22 F 1,133 Yes 38.3 1 No NA 2 Infiltrates/Atelectasis Negative 18,450 34.0 Wheezing Episode Yes No
23 M 1,590 No NA NA No NA 2 Not Performed Not Performed ND ND Wheezing Episode No No
24 F 969 Yes 39.5 5 Yes 1 3 Infiltrates/Atelectasis Negative 5,900 30.0 Pneumonia Yes No
25 M 246 No NA NA Yes 3 5 Not Performed Not Performed ND ND Wheezing Episode No No
26 M 690 Yes 39.6 1 Yes 3 4 No Alterations Not Performed ND ND Wheezing Episode No No
27 M 56 No NA NA Yes 5 6 No Alterations Not Performed ND ND Bronchiolitis No No
28 M 188 No NA NA Yes 2 3 Not Performed Not Performed ND ND Asthma No No
29 F 1,113 Yes 39.0 2 Yes 2 3 Infiltrates/Atelectasis Not Performed ND ND Wheezing Episode No No
30 F 113 No NA NA Yes 1 4 Not Performed Not Performed ND ND Bronchiolitis No No
31 M 331 Yes 38.5 4 Yes 1 3 No Alterations Not Performed ND ND Bronchiolitis Yes Yes
32 M 143 Yes 39.2 3 No NA 1 Infiltrates/Atelectasis ND 27,980 35.0 Bronchiolitis Yes No
33 M 685 No NA NA Yes 1 4 No Alterations Not Performed ND ND Wheezing Episode No No
34 F 1,013 Yes 38.8 3 Yes 1 4 Infiltrates/Atelectasis Negative 6,920 12.0 Wheezing Episode No No
35 F 37 Yes 38.5 1 No NA 9 Not Performed Negative 15,980 8.0 FWS Yes No
36 M 377 Yes 39.0 3 No NA 3 Not Performed Negative 16,370 124.0 URTI Yes Yes
37 F 1,641 Yes 39.0 5 Yes 1 4 Infiltrates/Atelectasis Negative 11,760 76.0 Pneumonia Yes Yes
38 F 1,702 Yes 38.0 1 Yes 1 2 Infiltrates/Atelectasis Not Performed ND ND Asthma No No
39 M 22 Yes 38.0 1 No NA 2 Not Performed Negative 10,530 1.0 URTI No No
40 M 1,929 No NA NA Yes 1 3 No Alterations Not Performed 17,150 28.0 Wheezing Episode No No
41 M 1,980 Yes 39.0 7 No NA 2 Infiltrates/Atelectasis Negative 9,760 7.0 Pneumonia Yes No
42 M 1,675 Yes 39.0 7 No NA 5 Infiltrates/Atelectasis Negative 6,300 27.0 Pneumonia Yes No
43 M 642 Yes 39.5 7 No NA 7 No Alterations Negative 18,470 29.0 FWS No No
44 F 20 No NA NA ND ND 5 Not Performed Not Performed 9,000 0.6 ALTE No No
45 M 0 No NA NA No NA 2 Not Performed ND ND ND URTI No No
46 M 129 Yes 38.5 11 No NA 7 Infiltrates/Atelectasis Negative 16,200 36.0 Pneumonia No No
47 M 5,203 Yes 40.5 3 No NA 3 Infiltrates/Atelectasis ND 9,900 18.0 Asthma Yes No
48 M 34 No NA NA No NA ND Not Performed ND ND ND Bronchiolitis No No






and by vortexing, centrifuged at 5,000×g for 10 min at
room temperature, and filtered through a 0.45 μm
pore-size filter (Ultrafree-MC, Millipore, Massachu-
setts, USA) [24,25]. Each filtrate was processed with
the RNeasy Micro kit (Qiagen, Maryland, USA) per-
forming an on-column DNA digestion following the
manufacturer’s protocol. RNA extracts were then
amplified by SISPA RT–PCR as described previously
[6,8]. Amplification products were purified with the
MinElute PCR purification kit (Qiagen), sheared
using the Covaris S2 instrument (Covaris, Massachu-
setts, USA), and used for Illumina library preparation
in the Apollo 324 NGS Library Prep System with the
PrepX ILM 32i DNA Library Kit (Wafergen Biosys-
tems, California, USA). Libraries were barcoded with
non-overlapping dual indexes, pooled and sequenced
using either a MiSeq instrument with a MiSeq Reagent
kit v2 (Illumina, California, USA) or a NextSeq 500 sys-
tem with a NextSeq 500/550 Mid Output v2 kit, both
with 2×151-bp reads (Supplementary Methods – Sup-
plementary Table 2).
Data analysis was performed as follows: Cutadapt
v1.7 [26], Prinseq-lite v0.20.4 [27] and Picard (http://
broadinstitute.github.io/picard), were used for removal
of adaptors, primers, PCR duplicates, and for quality
filtering of the index (<30 Phred) and reads (<20
Phred). Removal of reads belonging to the host was
performed by aligning the quality-trimmed reads to
the human genome reference GRCh38 (https://www.
ncbi.nlm.nih.gov/genome/guide/human) with Bowtie2
v2.1.6 [28]. After the host removal step, reads were sub-
jected to de novo assembly using Ray v2.2 [29].
Assembled contigs (109–28,945 bp) were taxonomi-
cally identified through sequence similarity to the
nucleotide collection (nr/nt) database in GenBank
using NCBI BLAST v2.2.28+ (megablast and dc-mega-
blast; e-value threshold of 1×10E−04). Those contigs
with no match were analysed with ORFfinder
(https://www.ncbi.nlm.nih.gov/orffinder/) and the
identified ORFs were compared to the non-redundant
protein sequences (nr) database in GenBank by
BLASTx analysis (e-value threshold of 100).
Unmapped reads were aligned to the nr database in
GenBank with DIAMOND, using sensitive mode
[30]. Negative controls consisting on sterile RNase-
free water were processed in parallel with the respirat-
ory specimens. Hits identified in the negative controls
were considered as laboratory contaminants and not
reported (Suplemmentary Methods). The results from
the BLASTn and BLASTx analysis were manually
curated and those contigs backed up by reads with
no paired mate, as well as those that matched repeat-
edly to low complexity genomic regions or to endogen-
ous and integrated viral sequences were discarded. All
sequencing data generated in this study have been
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Virus detection by contig-specific RT–PCR
analysis
All those NPA specimens that contained reads of any
respiratory virus were analysed by RT–PCR in order
to confirm the results of the HTS analysis. Primer
pairs were designed with the viral nucleotide sequence
information obtained in the HTS analysis (Supplemen-
tary Table 1). RT–PCR was performed in 5 µl of the
same RNA extracts that were initially used in the HTS
analysis. Assays were performed with the AgPath-ID
One-Step RT–PCR kit (ThermoFisher Scientific, Mas-
sachusetts, USA) following themanufacturer’s protocol.
Amplification conditions were as follows: 30 min at 45°
C, 10 min at 95°C, 40 cycles of 30 s at 95°C, 30 s at 60°C
and 1 min at 72°C, followed by a final extension step of
7 min at 72°C. RT–PCR products were analysed in 2%
agarose gel electrophoresis, purified with the MinElute
PCR Product Purification Kit (Qiagen), and sequenced
with the BigDye Terminator v3.1 Cycle Sequencing Kit
(Life Technologies, California, USA).
Results
Viruses identified by target-agnostic high-
throughput sequencing analysis
Target-agnostic HTS analysis of the 57 nasopharyngeal
aspirates taken from the “Case” group produced a total
of 24.6 million reads and 35,666 contigs that were tax-
onomically identified by BLASTn analysis (Figure 1
(a)). A total of 35,226 contigs (with 42.3 million
reads) were identified by BLASTn analysis from the
samples taken from the “Control” group (Figure 1
(b)). In the “Case” group, contigs assigned to viruses
represented 14.4% (5,117 contigs), while viruses rep-
resented 7.1% (2,486 contigs) in the “Control” group
(Figures 1(a,b)).
Among the 5,117 contigs assigned to viruses in the
“Case” group, 13% (667 contigs with 2.6 million
reads mapped) corresponded to viruses that infect
eukaryotic organisms, while 87% (4,450 contigs with
4.1 million reads mapped) corresponded to bacterio-
phages. Among the contigs assigned to viruses that
infect eukaryotic organisms 9 different families were
identified namely, Papillomaviridae, Pneumoviridae,
Picornaviridae, Paramyxoviridae, Anelloviridae, Coro-
naviridae, Circoviridae, Orthomyxoviridae, and Polyo-
maviridae (Figure 1(c)). Altogether, the number of
contigs assigned to any respiratory viral pathogen
accounted for 51% (340 contigs) (Table 2). When
taking into account the number of reads, the vast
majority (99.7%; 2.54 million reads) mapped to any
of the 340 contigs assigned to respiratory viral patho-
gens (Table 2). Among these, Human orthopneumo-
virus (Human respiratory syncytial virus; HRSV) and
Human rhinovirus (HRV) were the most frequently
Figure 1. Taxonomic identification and relative abundance of the contigs from the respiratory specimens taken from the pediatric
patients diagnosed with an infection of the lower respiratory tract (A and C) and of those from the specimens taken from the control
group (B and D). The category “Others” includes various types of cloning, expression and mutagenesis plasmids, synthetic clones,
and uncultured organism clones.
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identified, followed by Enterovirus (EV) and Human
rubulavirus (Human parainfluenza virus; HPIV),
Human coronavirus (HCoV), Influenza B virus, and
Human metapneumovirus (HMPV) (Table 2).
Altogether, at least one respiratory viral pathogen
could be identified by target-agnostic HTS analysis in
35 out of the 57 NPA specimens. Other viruses ident-
ified in these samples included: Sapelovirus A,
Human parechovirus 1 (HPeV-1), Human papilloma-
virus (HPV), Human PoSCV5-like circular virus, Tor-
que teno virus, Torque teno mini virus, and Human
polyomavirus 4 (WU polyomavirus) (Table 2).
From the 70 respiratory specimens taken from the
“Control” group, 5.9% of the contigs (147 contigs
with 951,625 reads mapped) corresponded to viruses
that infect eukaryotic organisms, while 94.1% (2,339
contigs with 4.4 million reads mapped) corresponded
to bacteriophages. Among the contigs assigned to
viruses that infect eukaryotic organisms, members of
the Papillomaviridae, Circoviridae, Pneumoviridae,
Anelloviridae, Picornaviridae, Herpesviridae, Totiviri-
dae, Virgaviridae, and Reoviridae were identified
(Figure 1(d)). Viral respiratory pathogens were ident-
ified only in two specimens. One produced 4 contigs
that were identified as HMPV, with the vast majority
of the reads mapping to them (99.1%; 943,278 reads)
(Table 2). In a second specimen, HRV was identified,
with 2 contigs to which 5 reads mapped. The remaining
8,342 reads mapped to a total of 141 contigs identified
as the following viruses: HPV, Human PoSCV5-like
circular virus, Torque teno virus, Red clover powdery
mildew associated totivirus, Tobacco mosaic virus,
Rotavirus A, and Human betaherpesvirus 5 (Table 2).
Viruses detected by contig-specific RT–PCR
analysis
Results of the contig-specific RT–PCR assays
confirmed those of the target-agnostic HTS analysis.
In the “Case” group, HRSV and HRV were the most
prevalent viruses, followed by EV and HPIV, HCoV,
Influenza B virus, and HMPV (Table 3). In the “Con-
trol” group, the two NPA where HMPV and HRV
had been identified by HTS analysis were confirmed
to be positive for these viruses (Table 3).
Several specimens among the “Case” group con-
tained more than one virus (Table 4). Among these
co-infections, HRSV was detected with either HPIV,
EV or HRV, and HCoV was detected along with
HRV (Table 4). No co-infections were detected in the
“Control” group.
Specimens with unexplained results taken from
cases with respiratory infection
In 22 out of the 57 (38.6%) NPAs taken from the cases
of respiratory infection the target-agnostic HTS analy-
sis did not identify any known respiratory viral patho-
gen (Table 5). In these samples, only bacteriophages,
Torque teno virus, HPV, Human PoSCV5-like circular
Table 2. Viruses that infect eukaryotic organisms identified by target-agnostic HTS in the respiratory specimens from the cases of
respiratory infection and from the control group.
Cases of respiratory infection Control group
Family Genera Virus Contigs Reads Samples Contigs Reads Samples
Pneumoviridae Orthopneumovirus Human orthopneumovirus A 120 1,669,448 14 – – –
Human orthopneumovirus B 5 14,194 1 – – –
Human orthopneumovirus 16 44 4 – – –
Metapneumovirus Human metapneumovirus 3 471,167 1 4 943,278 1
Picornaviridae Enterovirus Enterovirus B 7 739 1 – – –
Enterovirus D68 11 205,365 3 – – –
Rhinovirus A 27 41,472 5 2 5 1
Rhinovirus B 13 652 2 – – –
Rhinovirus C 50 22,535 8 – – –
Sapelovirus A 1 115 1 – – –
Parechovirus Human parechovirus 1 21 153 1 – – –
Coronaviridae Betacoronavirus Human coronavirus HKU1 23 8,246 1 – – –
Human coronavirus OC43 1 80,495 1 – – –
Human coronavirus NL63 5 19 1 – – –
Paramyxoviridae Rubulavirus Human rubulavirus 4 56 29,595 4 – – –
Orthomyxoviridae Betainfluenzavirus Influenza B virus 3 18 2 – – –
Papillomaviridae Betapapillomavirus Human papillomavirus 250 4,834 37 127 6,516 24
Circoviridae unclassified Human PoSCV5-like circular virus 20 289 10 5 14 3
Anelloviridae Alphatorquevirus Torque teno virus 20 233 9 3 1,643 3
Betatorquevirus Torque teno mini virus 14 2,096 4 – – –
Polyomaviridae Betapolyomavirus Human polyomavirus 4 (WU polyomavirus) 1 3 1 – – –
Totiviridae unclassified Red clover powdery mildew associated
totivirus
– – – 2 124 1
Virgaviridae Tobamovirus Tobacco mosaic virus – – – 1 31 1
Reoviridae Rotavirus Rotavirus A – – – 1 2 1
Herpesviridae Cytomegalovirus Human betaherpesvirus 5 – – – 2 12 1
Total 667 2,551,712 147 951,625
Notes: Samples were treated as two separate groups (cases of respiratory infection versus age-matched control group) and contigs and reads were grouped
by virus within each group. Contigs: number of contigs that match the indicated virus. Reads: total number of reads mapping to the corresponding contigs.
Samples: number of specimens where contigs and reads matching the indicated virus were identified.
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virus, and Human polyomavirus 4 (WU polyomavirus)
were identified (Table 5).
Further analysis of the unidentified contigs
assembled from these samples by looking for sequence
homologies to known viral proteins (BLASTx)
returned no significative results. Although some hits
to viral proteins were identified, all of these contigs
mapped also to other protein sequences in the Gen-
Bank database with the same e-values, and with com-
parable ranges of coverage and identity percentage
values, and thus could not be considered viral-specific
hits. Representative examples of such kind of identifi-
cations are shown in Table 6. Reads that did not
form contigs were mapped against the nr Genbank
database with DIAMOND [30]. The analysis showed
that those reads matched to proteins of bacterial or
human origin or belonging to bacteriophages, and no
putative novel virus was identified (results not shown).
We compared the bacterial hits identified by target-
agnosticHTS analysis in these sampleswith those ident-
ified in the specimens taken from the control group. Sev-
eral contigs were identified by BLASTn analysis as well-
recognized bacterial respiratory pathogens, such as
Streptococcus pneumoniae, Haemophilus influenzae,
and Klebsiella pneumoniae. However, all these hits to
bacterial respiratory pathogens were not exclusive of
the specimens taken from the cases of respiratory infec-
tion and could be identified also in the specimens taken
from the control group (results not shown). Since our
analysis is not designed to be quantitative, no con-
clusions regarding frequency could be made.
Discussion
Between 2012 and 2013, we tested by multiplex real-
time RT–PCR [21–23] a total of 1,454 specimens
from pediatric respiratory infections. Out of these, 57
remained negative after the analysis with different mol-
ecular assays. In order to shed light on the etiology of
these infections, these 57 specimens were subjected to
target-independent HTS analysis, along with 70 age-
Table 3. Respiratory viral pathogens identified by target-agnostic HTS analysis and confirmed by contig-specific molecular assays in
the respiratory specimens from the cases of respiratory infection and from the control group.
Cases of respiratory infection Control group
Virus Contigs Reads Positive specimens Contigs Reads Positive specimens
Human orthopneumovirus 141 1,683,686 15 – – –
Human metapneumovirus 3 471,167 1 4 943,278 1
Enterovirus 18 206,104 4 – – –
Human coronavirus 29 88,760 3 – – –
Rhinovirus 90 64,659 12 2 5 1
Human rubulavirus 56 29,595 4 – – –
Influenza B virus 3 18 2 – – –
Notes: Contigs: number of contigs that match the indicated virus. Reads: total number of reads mapping to the corresponding contigs. Positive specimens:
number of specimens where reads matching the indicated virus were identified and confirmed by contig-specific RT-PCR analysis.
Table 4. Respiratory viral pathogens identified by target-
agnostic HTS analysis and confirmed by contig-specific








Human orthopneumovirus 10 – 34.5
Human metapneumovirus 1 – 3.4
Enterovirus 2 – 6.9
Human coronavirus 2 – 6.9
Rhinovirus 10 – 34.5
Human rubulavirus 2 – 6.9













Notes: Single infections: number of specimens where only one virus was
detected by contig-specific molecular assays. Coinfections: number of
specimens where more than one virus was detected by contig-specific
molecular assays. %: percentage of specimens positive for each virus
over the total number of either single infections or coinfections.
Table 5. Viruses identified by target-agnostic HTS analysis in
the group of respiratory specimens taken from cases of















1 1 / 146 3 / 121 18 / 569 –
2 – 2 / 3 11 / 149 –
3 – – – –
4 – – – –
5 – – 1 / 1 1 / 3
6 – – 9 / 30 –
7 – – – –
8 – – – –
9 – – 1 / 2 –
10 – 3 / 12 3 / 195 –
11 – 2 / 6 9 / 104 –
12 – – 13 / 118 –
13 2 / 4 – 5 / 36 –
14 – 1 / 2 2 / 7 –
15 – – – –
16 – – 3 / 156 –
17 – 1 / 3 7 / 30 –
18 – – 1 / 4 –
19 – – 4 / 38 –
20 – – 4 / 215 –
21 – – 3 / 10 –
22 – 1 / 101 3 / 1,961 –
Notes: Contigs / Reads: number of contigs that match the indicated virus /
total number of reads mapping to the corresponding contigs.
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matched specimens from a control group. Similarly to
the 57 specimens from the respiratory infections, the
specimens from the control group resulted negative
in the aforementioned molecular assays.
Upon HTS analysis we further identified known
viral respiratory pathogens (HRSV, HRV, EV, HPIV,
HCoV, HMPV and Influenza B virus). Altogether, at
least one respiratory viral pathogen could be identified
in 35 out of the 57 NPA specimens from the group of
respiratory infection. By contrast, in the control group,
only 2 samples contained contigs attributed to viral res-
piratory pathogens (HMPV and HRV). Moreover, the
HMPV contigs detected in one of these samples,
hoarded the vast majority of the reads assigned to
any eukaryotic virus (99.1%). The remaining viral enti-
ties were anelloviruses and papillomaviruses common
to both groups.
Identification of respiratory viruses by HTS was
confirmed by contig-specific RT–PCR analysis. The
HMPV and HRV identified in the control group
occurred in two cases that showed no symptoms of res-
piratory disease. Asymptomatic infections by HRV
have been previously reported and are more frequent
in young children [31]. Although asymptomatic infec-
tions by HMPV can occur at the pediatric stage, they
are more frequent in immunocompetent adult individ-
uals [31–33].
Apart from common respiratory viral pathogens,
Human parechovirus 1 (HPeV-1) and Human polyo-
mavirus 4 (WU polyomavirus) were identified by
HTS analysis. Both viruses were identified in specimens
from the group of respiratory infection (1 sample
each); none in the control group. The detection of
HPeV-1 is not surprising as this virus is a frequent
cause of infection in childhood, where it causes mild
gastrointestinal and respiratory disease [34]. Human
polyomavirus 4 (WU polyomavirus) was originally
detected in respiratory secretions of a pediatric patient
diagnosed with pneumonia of unknown origin, and
from patients with acute respiratory co-infections
[35]. Nonetheless, a subsequent larger study found no
link between WU polyomavirus and acute respiratory
disease [36]. In our study, WU polyomavirus was
identified in one case of respiratory infection. Although
no other respiratory virus was identified in this sample,
WU polyomavirus presents low prevalence in cases of
respiratory infection and high rates of co-infection
with other common respiratory viral pathogens, and
further studies are needed to ascertain its clinical sig-
nificance [35–37].
Thus, out of 57, 21 (36.84%) remain unexplained
from a virological standpoint, as no known respiratory
or novel virus was identified. Analysis by BLASTn only
returned matches to anelloviruses, papillomaviruses,
Table 6. Representative examples of matches in GenBank identified by BLASTx analysis of the contigs that remained unassigned to








c42_2 372 hypothetical protein 1 [Wallerfield virus] 29 34.43 61 35
sugar O-acyltransferase [Yokenella regensburgei] 4.8 30 60 37.0
LysE family translocator [Pelosinus propionicus] 11 30 80 36.2
hypothetical protein WG66_1665 [Moniliophthora roreri] 12 41.94 31 36.2
hypothetical protein OBBRIDRAFT_890634 [Obba rivulosa] 16 41.94 31 35.8
dynein 1 light intermediate chain [Moniliophthora roreri MCA 2997] 19 41.94 31 35.4
hypothetical protein CONPUDRAFT_168928 [Coniophora puteana RWD-64-598
SS2]
20 41.94 31 35.4
PREDICTED: radial spoke head 10 homolog B-like [Eufriesea mexicana] 25 42.42 33 35.0
c99_1 324 replicase polyprotein [Porcine deltacoronavirus] 828 31.94 72 35.4
hypothetical protein SSIN_1445 [Streptococcus sinensis] 149 34.55 55 34.7
hypothetical protein [Streptococcus sp. DD04] 314 34.55 55 33.9
DNA polymerase/3’-5’ exonuclease PolX [Bacillus sp. EB01] 281 29.73 74 33.9
hypothetical protein [Cohnella sp. 6021052837] 301 39.58 48 33.9
hypothetical protein FisN_9Lh049 [Fistulifera solaris] 320 43.33 60 33.9
DNA polymerase/3’-5’ exonuclease PolX [Bacillus acidiproducens] 281 29.85 67 33.1
c859_5 630 hypothetical protein 1 [Wenzhou picorna-like virus 53] 1,170 26.67 180 39.3
O-methylsterigmatocystin oxidoreductase [Trametes pubescens] 377 36.11 72 39.7
glutamine–tRNA ligase [Acinetobacter sp. WC-141] 10 25.34 221 38.5
predicted protein [Postia placenta Mad-698-R] 12 31.36 118 38.1
cell adhesion molecule-related/down-regulated by oncogenes [Calidris
pugnax]
27 28.42 95 37.4
hypothetical protein FOMPIDRAFT_1024183 [Fomitopsis pinicola FP-58527
SS1]
67 31.51 73 35.8
aldehyde dehydrogenase [Thermomicrobium roseum] 72 39.29 56 35.8
TFIIH basal transcription factor complex, subunit SSL1 [Xylona heveae TC161] 87 27.78 108 35.4
c510_1 375 putative transposase [Saudi moumouvirus] 0.46 28.85 104 40.0
photosystem I reaction centre subunit XII [Nostoc sp. DB3992] 0.48 36.44 118 40.0
photosystem I reaction centre subunit XII [Nostoc sp. KVJ20] 5.9 34.75 118 37.0
transmembrane protein, putative [Tetrahymena thermophila SB210] 7.6 30.30 99 37.0
phycobilisome Linker polypeptide/CpcD/allophycocyanin [Oscillatoria
acuminata]
8.7 33.33 108 36.6
CoA transferase [Candidatus Contendobacter odensis] 12 35.00 60 36.2
1,4-alpha-glucan-branching protein [Hymenobacter gelipurpurascens] 14 31.88 69 36.2
hypothetical protein [Enterovibrio calviensis] 14 30.11 93 35.8
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and Human PoSCV5-like circular virus. In spite of
thorough, in-depth analysis of those contigs with no
match as well as of the unmapped reads, no viral
match in the GenBank database was obtained. Anello-
viruses are frequently detected in most tissues and
organs, including the respiratory tract of healthy indi-
viduals, and there is no association to any disease in
humans [38]. Papillomaviruses are very common
worldwide, and most infections are asymptomatic
and resolve spontaneously. Apart from the common
warts and the various types of cancer (including an
oropharyngeal form) associated to infection by HPV,
low-risk types 6 and 11 are the predominant cause of
respiratory papillomatosis, a disease in which noncan-
cerous tumours grow in the air passages of the respir-
atory tract [39]. However, other than oropharyngeal
cancer and respiratory papillomatosis, there is no evi-
dence of an association between papillomavirus infec-
tion and respiratory disease. In addition to the lack of
evidence for an association with respiratory disease,
in our study anelloviruses and HPV were also ident-
ified in the control group, strengthening the conclusion
that their presence was not related to the respiratory
disease. Human PoSCV5-like circular virus was
recently identified in respiratory secretions from an
unexplained human case of febrile illness, although
its association with disease was not determined [40].
Small, circular, single stranded, REP-encoding, DNA
(CRESS-DNA) viruses have been increasingly ident-
ified by metagenomic HTS techniques [41] in environ-
mental samples and in a variety of vertebrates as well as
various invertebrates [42–45]. In humans, they have
been reported in feces of healthy individuals [43],
and in samples from unexplained cases of encephalitis
and diarrhea [46], pericarditis [47], acute central ner-
vous system infections [48], as well as in NPAs from
children with respiratory infections [49]. However,
neither of these studies could establish a direct associ-
ation with disease. Thus, it is not clear what is the value
of finding contigs that match this virus in the speci-
mens from the group of respiratory infection. Further
studies are needed to determine their role (if any) in
human respiratory disease.
Our findings agree with previous studies with simi-
lar design and tools [25,50,51]. Xu et al. employed HTS
to analyse a set of respiratory specimens taken from
children with community-acquired pneumonia that
had returned negative results in a commercial respirat-
ory viral panel detection assay [25]. They also identified
HPIV, Torque teno virus, Torque teno minivirus, and
WU polyomavirus [25]. Zhou et al. studied cell-cul-
tured supernatants with apparent cytopathic effect
that had been prepared from undiagnosed respiratory
specimens and identified a high prevalence of EV
accompanied by HRV, HRSV, HPIV, AdV, Influenza
C virus, Herpesvirus 1 and Dengue virus [51]. Taboada
et al. studied nasal washings from children with
respiratory infections previously found negative for
common bacterial and viral respiratory pathogens by
PCR, where they identified at least one known respirat-
ory virus (including HRSV, HCoV, and HRV) in the
vast majority of the specimens [50]. Neither of these
studies revealed the presence of any putative novel
virus on the undiagnosed respiratory infections subject
of study, and the large majority of the cases could be
attributed to known viral respiratory pathogens
[25,50,51]. These studies suggest that all respiratory
viral pathogens of clinical relevance during the pedi-
atric stage have already been identified. In our study,
we analysed 57 cases that, out of a total of 1,454,
were negative in all pathogen-specific PCR assays. In
consequence, only 3.9% (57/1,454) of all respiratory
specimens collected during the entire epidemic season
remained without a known etiology of infection after
using pathogen-targeted diagnostic techniques. While
target-independent HTS analysis allowed us to come
to a specific diagnostic in more than half of the 57
undiagnosed infections, all the additionally resolved
cases were produced by known respiratory pathogens.
From these results, we can conclude that the current
pathogen-specific techniques should be able to diag-
nose the vast majority of the respiratory infections. In
consequence, we can conclude that the risk of over-
looking a novel unknown viral respiratory pathogen
in the pediatric population is very low when using tar-
get-specific diagnostic methods and that there is very
little value in using target-independent assays. Routine
virological surveillance based on target-specific tech-
niques, such as real-time (RT)PCR or target enrich-
ment HTS approaches (which use probes specifically
designed against the viral genomic sequence of interest
in order to enrich specifically for sequencing libraries
derived from said virus), is appropriate and constitute
a first-line diagnostic tool.
The question about the etiology behind those cases
of respiratory infection that remain negative for all rou-
tine diagnostic assays have been previously addressed
by several groups [24,25,50–52]. Although in our
study we used an overall approach which was similar
to such previous studies, we introduced several
improvements to our specific study design in order to
address different limitations of the previous works.
The identification of viral reads in clinical specimens
remains controversial because it does not necessary
imply that such viruses are responsible for the symp-
toms observed. Many viruses can cause asymptomatic
or subclinical infections, or simply be present among
the normal, healthy microbiota and replicate without
any pathogenic consequences. This hinders the
interpretation and understanding of the results
unveiled by virus discovery studies based on HTS in
regard to their clinical significance [25,50,51]. In our
study, we included a contrast study population (control
group) formed by a prospective cohort of healthy
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individuals. Such healthy control group was matched at
all the critical levels with the cohort of patients with
unexplained infection of the respiratory tract: (i) The
individuals of the control group were age-matched;
(ii) They came from the same geographic area; (iii)
Their samples were also taken systematically during
the same time window covering the epidemic season
of virus circulation. By including the control group,
we were able to determine that the viruses detected in
the clinical specimens taken from the patients with
an infection of the respiratory tract were not circulating
among the healthy population, providing evidence that
such viruses were responsible for the respiratory dis-
ease observed in those cases. This would acquire special
importance if a novel viral entity for which there is no
previous information available is detected. In sum-
mary, the inclusion of the healthy control group
allowed us to assess the clinical relevance of the viruses
identified in the samples taken from the cases of unex-
plained respiratory infections. Whenever possible, any
future viral discovery studies should include a matched
healthy control group to which the viruses identified by
HTS in the patients with clinical disease can be
contrasted.
In addition to the inclusion of a matched healthy
control group, we processed and sequenced in parallel
negative controls consisting on sterile nuclease-free
water (see the Materials and Methods section) and
we confirmed the viral identifications made by HTS
with specific RT–PCR assays. The objective of these
procedures was to minimize the chances of reporting
any false viral identification. It is worth highlighting
also, that we performed a systematic sampling on our
study groups: samples were collected from all the chil-
dren arriving consecutively at the hospital during the
period of the study, whose parents or legal guardians
gave explicit written consent, and according to pre-
established clinical and medical criteria (see the
Materials and Methods section) with no further selec-
tion. By combining all the procedures discussed
above, our study design constitutes a novel integrated
approach that ensures a robust representativeness of
the results, minimizes any possible bias, and provides
a better understanding about the clinical implications
of the viral identifications made by HTS analysis.
While HTS was superior in the overall rate of detec-
tion of pathogens, that was not due to the presence in
the cohort of unknown pathogens, but mostly on the
underperformance of molecular methods (real-time
RT–PCR) against targeted pathogens. All the viruses
additionally identified by HTS in our study were
well-known respiratory pathogens, and no novel
viruses were detected. Altogether, our results show
that already known viral respiratory pathogens play a
main etiologic role behind the unexplained cases of res-
piratory infection in the pediatric population. This is a
very significant finding, because if extrapolated to other
clinical syndromes and specimens, it might allow us to
quantitatively assess the risk. Under that new para-
digm, “Agnostic” technologies would still have a role
in pathogen detection under outbreak and event situ-
ations where a true “unknown unknown” is suspected,
but “Targeted” approaches would become desirable for
Next-generation sequencing-based microbial diagnos-
tic. This paradigm might be desirable from a regulatory
standpoint for those diagnostic laboratories seeking to
incorporate these technologies, since “Targeted”
approaches allow for specific and reproducible library
enrichment and thus they are easier to assess and
validate.
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